HJURP and renal carcinoma: A previous study had shown that HJURP silencing inhibited the proliferation of human renal cancer CAKI-1 cells, arresting them in G2/M phase, and diminished their migratory capacity by inhibiting EMT and downregulating p-AKT and p-GSK3β (Patel et al., 2014).